Comment by yread
become an professor and try some immunotherapy like prof. Long and prof. Scolyer?
become an professor and try some immunotherapy like prof. Long and prof. Scolyer?
He tried an experimental payload that contained two ADCs, one BRAF inhibitor and something else, maybe PD-1 inhibitor. Then he had surgery. Payload-heavy ADCs are the way forward against difficult cancers.
They're using weakened viruses. Virus use in cancer is nothing new, but an interesting field. I can see why pharma hesitates using it, viruses can mutate, too, similar to cancer. https://pakrozee.pk/
As of his latest scan in November, 18 months post surgery, Scolyer's cancer hasn't recurred [1]. Average time to recurrence post-surgery is 6 months.
Don't want to leap to conclusions prematurely, but that might be some progress.
[1] https://x.com/ProfRAScolyer/status/1859179205885673877